215 filings
Page 5 of 11
UPLOAD
urokdk0kwt1tmbjhdu
29 Sep 20
Letter from SEC
12:00am
8-K
vvfcp0tjz79o9zxh
13 Aug 20
Novocure Announces Expansion of its Executive Leadership Team
8:45am
8-K
c3n62km
6 Aug 20
Termination of a Material Definitive Agreement
4:09pm
8-K
eh0jfz lz81t276w
30 Jul 20
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
8:11am
8-K
9ayqzwb
15 Jul 20
Regulation FD Disclosure
10:38am
8-K
xocw5mapf0rzuz4chr
12 Jun 20
Departure of Directors or Certain Officers
4:10pm
8-K
zl3kv6h1 6c3i309
13 May 20
China NMPA Approves OptuneĀ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
10:19am
8-K
xnkyyan96o39j
30 Apr 20
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
6:13am
DEFA14A
9xpri
27 Apr 20
Additional proxy soliciting materials
4:45pm
8-K
o8c57ii g8
24 Apr 20
Departure of Directors or Certain Officers
5:19pm
8-K
9qhjnhu
6 Mar 20
Departure of Directors or Certain Officers
4:19pm
S-8
bpa33oqr
3 Mar 20
Registration of securities for employees
4:05pm
8-K
65deuymd41jy7acbk
27 Feb 20
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
6:07am
8-K
8lyujr2i
13 Jan 20
Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update
7:25am